|
| 37349744 | Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus. | | 2023 |
| 35642868 | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE. | Rheumatology | 2023 |
| 35383519 | Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis. | Scandinavian Journal of Rheumatology | 2023 |
| 36124819 | Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis. | Scandinavian Journal of Rheumatology | 2023 |
| 37954916 | How is the patient perspective captured in ANCA-associated vasculitis research? An integrative review. | | 2023 |
| 36508734 | Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus. | | 2023 |
| 37004177 | Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis. | Rheumatology (Oxford) | 2023 |
| 36562566 | Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study. | | 2023 |
| 36804380 | Identification of proteinase 3 autoreactive CD4T cells and their T-cell receptor repertoires in antineutrophil cytoplasmic antibody-associated vasculitis. | | 2023 |
| 37439924 | Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study. | | 2023 |
| 37368057 | Occurrence and localization of FOXP3â¿¿+â¿¿cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis. | | 2023 |
| 34888651 | Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA. | Rheumatology (Oxford) | 2022 |
| 35464461 | Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity. | Frontiers in Immunology | 2022 |
| 36104119 | Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. | Lupus Science and Medicine | 2022 |
| 36332927 | Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease. | Lupus Sci Med | 2022 |
| 35993015 | Exploring the educational needs of patients with systemic vasculitis using the educational needs assessment tool. | Rheumatology Advances in Practice | 2022 |
| 35729719 | Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome. | Arthritis Rheumatol | 2022 |
| 35315244 | Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. | Arthritis Rheumatol | 2022 |
| 34981775 | The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. | J Clin Invest | 2022 |
| 35246487 | Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus. | Lupus Science and Medicine | 2022 |
| 35020891 | Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatment. | Clinical and Experimental Immunology | 2022 |
| 34658170 | Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. | ACR Open Rheumatology | 2022 |
| 34526357 | Infection hospitalisation in systemic lupus in Sweden. | Lupus Science and Medicine | 2021 |
| 34127828 | Variants in BANK1 are associated with lupus nephritis of European ancestry. | Genes and Immunity | 2021 |
| 33972457 | Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity. | Lupus Science and Medicine | 2021 |
| 34290127 | Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. | Lupus Science and Medicine | 2021 |
| 34012450 | False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases. | Front Immunol | 2021 |
| 33957795 | Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE. | Lupus | 2021 |
| 33685997 | Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies. | Lupus Science and Medicine | 2021 |
| 33576004 | Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid. | Clinical and Experimental Immunology | 2021 |
| 33840282 | The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus. | Lupus | 2021 |
| 34046573 | Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus. | | 2021 |
| 34093522 | A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis. | Frontiers in Immunology | 2021 |
| 33766895 | Interaction between the rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus. | Annals of the Rheumatic Diseases | 2021 |
| 33377143 | Erratum to: Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. | Rheumatology | 2021 |
| 32994161 | Toll-like receptors revisited; a possible role for TLR1 in lupus nephritis. | Ann Rheum Dis | 2021 |
| 32989505 | Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift? | Clinical Rheumatology | 2021 |
| 33367774 | Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment. | Rheumatology | 2021 |
| 33037003 | Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing. | Ann Rheum Dis | 2021 |
| 32977027 | Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay. | | 2021 |
| 33341888 | De novo lupus nephritis during treatment with belimumab. | Rheumatology | 2021 |
| 33006609 | Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. | Rheumatology | 2021 |
| 32724065 | Contributions of de novo variants to systemic lupus erythematosus. | European Journal of Human Genetics | 2021 |
| 33412597 | The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies. | Thrombosis and Haemostasis | 2021 |
| 34389040 | First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis. | | 2021 |
| 34659263 | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study. | Frontiers in Immunology | 2021 |
| 35116030 | Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature. | Frontiers in Immunology | 2021 |
| 31371653 | Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis. | Journal of Rheumatology | 2020 |
| 32259250 | Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus. | Rheumatology | 2020 |
| 32422945 | Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus. | International Journal of Molecular Sciences | 2020 |